APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese

被引:32
|
作者
Chien, Kuo-Liong [2 ]
Fang, Woei-Horng [1 ]
Wen, Hui-Chin [1 ]
Lin, Hsing-Pei [1 ]
Lin, Yen-Lin [1 ]
Lin, Shu-Wha [1 ]
Wu, June-Hsieh
Kao, Jau-Tsuen [1 ,3 ]
机构
[1] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Publ Sch, Inst Prevent Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei 100, Taiwan
关键词
apolipoprotein A1/C3/A5; triglyceride; HDL cholesterol; haplotype;
D O I
10.1016/j.cca.2007.12.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Apolipoprotein A5 gene (APOA5) has been shown to modulate plasma triglyceride concentrations. We investigated 2 distinct APOA1/C3/A5 haplotypes roles for hypertriglyceridemia. Methods: We recruited 308 cases of hypertriglyceridemia and 281 normal controls from a hospital. Twelve single nucleotide polymorphisms (SNPs) across the APOA1/C3/A5 gene region were genotyped. Results: One haplotype containing the minor alleles of the APOA5 (-1131T>C, c.553G>T) and APOA1 (-3013C>T,-75G>A) was more prevalent in cases than in controls (11.3% vs. 1.1%, respectively) and was statistically significantly associated with high triglycerides (adjusted odds ratio: 12.83, 95% confidence interval [CI]: 5.1-32.4, P<0.001). Another haplotype that was associated with hypertriglyceridemia (adjusted odds ratio 2.13, 95% CI, 1.37-3.29, P=0.001). Participants carrying both minor alleles of APOA5-1131CC and c.553TT had a 116% higher triglyceride concentration compared with those carrying common allele. Conclusions: The APOA1/C3/A5 haplotype represents an important locus for predicting risk of hypertriglyceridemia among Taiwanese. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 50 条
  • [41] Overweight modulates APOE and APOA5 alleles on the risk of severe hypertriglyceridemia
    Lee, Ming-Jen
    Chien, Kuo-Liong
    Chen, Ming-Fong
    Stephenson, Dennis A.
    Su, Ta-Chen
    CLINICA CHIMICA ACTA, 2013, 416 : 31 - 35
  • [42] APOA1 polymorphism influences risk for early-onset nonfamiliar AD
    Vollbach, H
    Heun, R
    Morris, CM
    Edwardson, JA
    McKeith, IG
    Jessen, F
    Schulz, A
    Maier, W
    Kölsch, H
    ANNALS OF NEUROLOGY, 2005, 58 (03) : 436 - 441
  • [43] Interactions Between the Apolipoprotein A1/C3/A5 Haplotypes and Alcohol Consumption on Serum Lipid Levels
    Yin, Rui-Xing
    Li, Yi-Yang
    Wu, Jin-Zhen
    Pan, Shang-Ling
    Liu, Cheng-Wu
    Lin, Wei-Xiong
    Yang, De-Zhai
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2013, 37 (02) : 234 - 243
  • [44] Impact of APOA5/A4/C3 cluster genetic polymorphisms on lipid variables and cardiovascular disease risk
    Dallongeville, J
    Cottel, D
    Montaye, M
    Codron, V
    Amouyel, P
    Helbecque, N
    EUROPEAN HEART JOURNAL, 2003, 24 : 348 - 348
  • [45] Analysis of apolipoprotein A5, C3, and plasma triglyceride concentrations in genetically engineered mice
    Baroukh, N
    Bauge, E
    Akiyama, J
    Chang, J
    Afzal, V
    Fruchart, JC
    Rubin, EM
    Fruchart-Najib, J
    Pennacchio, LA
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) : 1297 - 1302
  • [46] In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction
    Tregouet, DA
    Ricard, S
    Nicaud, V
    Arnould, I
    Soubigou, S
    Rosier, M
    Duverger, N
    Poirier, O
    Macé, S
    Kee, F
    Morrison, C
    Denèfle, P
    Tiret, L
    Evans, A
    Deleuze, JF
    Cambien, F
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) : 775 - 781
  • [47] The ApoB/ApoA1 ratio as a determinant of cardiovascular risk at LDL cholesterol (LDL-c) therapeutic target levels
    Bergamasco, L.
    Onolfo, S.
    Pedrazzoli, R.
    Salviti, E.
    Sainaghi, P. P.
    Castello, L.
    Schianca, G. P. Carnevale
    Bartoli, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 49 - 49
  • [49] Low levels of ApoA1 improve risk prediction of type 2 diabetes mellitus
    Wu, Xing
    Yu, Zhexin
    Su, Wen
    Isquith, Daniel A.
    Neradilek, Moni B.
    Lu, Ning
    Gu, Fusheng
    Li, Hongwei
    Zhao, Xue-Qiao
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (02) : 362 - 368
  • [50] A potentially underestimated predictor of coronary artery disease risk: The ApoB/ApoA1 ratio
    Li, Bo
    Zhao, Xu
    Ding, Yan
    Zhang, Yi
    HELIYON, 2024, 10 (11)